On October 30, Shanghai Pharmaceuticals Holding Co., Ltd. (601607/02607) announced its plan to distribute a cash dividend of 1.2 yuan per 10 shares (tax inclusive) to all shareholders. The total payout is expected to reach 445 million yuan, accounting for 9.98% of the net profit attributable to the parent company.
In the first three quarters of 2025, Shanghai Pharmaceuticals reported revenue of 215.072 billion yuan and a net profit attributable to the parent company of 5.147 billion yuan.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.